Raymond James & Associates’s GE HealthCare GEHC Stock Holding History

Raymond James & Associates’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$39.5M	Buy	421,356 +39,654	+10%	+$3.33M	0.02%	525
2024 Q2	$29.7M	Buy	381,702 +36,076	+10%	+$2.94M	0.02%	598
2024 Q1	$31.4M	Buy	345,626 +32,511	+10%	+$2.71M	0.02%	579
2023 Q4	$24.2M	Sell	313,115 -16,399	-5%	-$1.15M	0.02%	653
2023 Q3	$22.4M	Buy	329,514 +47,456	+17%	+$3.45M	0.02%	633
2023 Q2	$22.9M	Buy	282,058 +54,007	+24%	+$4.31M	0.02%	639
2023 Q1	$18.7M	Buy	228,051 +217,577	+2,077%	+$15.5M	0.02%	713
2022 Q4	$611K	Buy	+10,474	New	+$604K	﹤0.01%	2751

Other funds holding GEHC

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Raymond James & Associates's GEHC Position: Q3 2024 in Review

Raymond James & Associates increased its GE HealthCare (GEHC) stake by 10% in Q3 2024, buying an estimated $3.33M and bringing the position to 421,356 shares worth $39.5M. The position accounts for 0.02% of the portfolio, ranked #525.

Raymond James & Associates first reported a position in GEHC in Q4 2022 and has held it in 8 quarters since. 1,274 funds tracked by Wall St. Rank hold GEHC as of Q3 2024.

Raymond James & Associates held 421,356 shares of GE HealthCare worth $39.5M as of Q3 2024.
Raymond James & Associates bought 39,654 GE HealthCare shares in Q3 2024, an estimated $3.33M.
GE HealthCare made up 0.02% of Raymond James & Associates's portfolio in Q3 2024, its #525 holding.
Raymond James & Associates first reported a position in GE HealthCare in Q4 2022 and has held it in 8 quarters since.
1,274 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.